Senti Biosciences Holdings (SNTI) Other Non Operating Income (2021 - 2025)

Senti Biosciences Holdings' Other Non Operating Income history runs 5 years deep, the most recent figure standing at $190000.0 for Q4 2025.

• In Q4 2025, Other Non Operating Income fell 7.77% year-over-year to $190000.0; the TTM figure through Dec 2025 stood at $768000.0 (up 282.09% YoY), while the FY2025 annual figure was $800000.0, up 300.0% from the prior year.
• Other Non Operating Income for Q4 2025 stood at $190000.0, down from $200000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $1.3 million in Q2 2022, with the low at -$54000.0 in Q1 2022.
• The 5-year median for Other Non Operating Income is $4000.0 (2022), against an average of $142437.5.
• The sharpest annual moves came in 2023 and 2025: Other Non Operating Income tumbled 800.0% in 2023, then surged 3233.33% in 2025.
• Senti Biosciences Holdings' Other Non Operating Income stood at $110000.0 in 2021, then sank by 103.64% to -$4000.0 in 2022, then slumped by 75.0% to -$7000.0 in 2023, then surged by 3042.86% to $206000.0 in 2024, then retreated by 7.77% to $190000.0 in 2025.
• Business Quant data shows SNTI's Other Non Operating Income at $190000.0 in Q4 2025, $200000.0 in Q3 2025, and $200000.0 in Q2 2025.